NASDAQ:XERS | Key Financial Ratios | Xeris Biopharma Holdings, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-301.45-25.95-4.17%176.34%
2026-03-312.123.06%92.29%
2025-12-312.1916.10.14%4.05%
2025-09-301.93-254.9-4.22%1816.49%
2025-06-301.95-11.33-9.56%165.76%
2025-03-311.72-6.54-14.29%128.32%
2024-12-311.67-7.84-16.97%185.16%
2024-09-301.79-8.17-19.66%222.83%
2024-06-302.26-17.96%308.85%
2024-03-312.37-19.13%701.69%
2023-12-311.64-28.15-19.30%917.94%
2023-09-301.82-18.85%-1598.84%
2023-06-301.95-21.73%-523.69%
2023-03-312.03-24.20%-258.85%
2022-12-312.54-27.48%-209.49%
2022-09-302.17-43.73%-240.77%
2022-06-302.5-42.90%-184.87%
2022-03-312.67-40.88%-143.10%
2021-12-311.8-40.32%-128.87%
2021-09-303.34-71.46%3811.13%
2021-06-30-421.27%
2021-03-31-181.06%
2020-12-315.4-57.27%-269.96%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-312.1916.10.14%4.05%
2024-12-311.67-7.84-16.97%185.16%
2023-12-311.64-28.15-19.30%917.94%
2022-12-312.54-27.48%-209.49%
2021-12-311.8-40.32%-128.87%
2020-12-315.4-57.27%-269.96%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.